Atlas Trials

Clinical Trial Assessing the Efficacy of Abscopal Effect Induced by SBRT and Immunotherapy in Advanced NSCLC

Clinical trial NCT04238169 · COMPLETED

Trial details

NCT number
NCT04238169
Sponsor
Xinqiao Hospital of Chongqing
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small-Cell Lung Cancer Stage IV
Start date
2020-09-01
Primary completion
2022-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.